Discover how RBM20 antisense oligonucleotides alleviate diastolic dysfunction in a mouse model of cardiometabolic heart failure, offering a novel therapeutic strategy for HFpEF.
Most Recent Articles
Nanobody Therapy for PsA: SLK Safety and Efficacy Data from a Phase 2 Study
A novel nanobody targeting the inflammatory IL-17 pathway has shown remarkable efficacy in patients with active Psoriatic Arthritis (PsA).
Two-in-One Protection: Evaluating the Trivalent Salmonella Polysaccharide Conjugate Vaccine
A new study evaluating a Trivalent Salmonella Conjugate Vaccine (TSCV) confirms its safety and reports 100% immunogenicity against key antigens, offering a promising solution to highly prevalent invasive disease in young children.
Delayed Diagnosis and Greater Disability: The Impact of ADHD on Adult Females
A new study evaluating sex differences in adult Attention-Deficit/Hyperactivity Disorder (ADHD) confirms that females are diagnosed significantly later than males and experience greater severity, depression, anxiety, and overall...
RZV Shows High, Consistent Protection for Immunocompromised and Immunocompetent Seniors
A new study evaluating the recombinant herpes zoster vaccine (RZV) in the Medicare population confirms its high effectiveness across both immunocompetent and immunocompromised older adults.